Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Feb;33(2):535-9.
doi: 10.1007/s00296-011-2179-1. Epub 2011 Nov 12.

Effects of dialysis on the pharmacokinetics of salazosulfapyridine

Affiliations
Case Reports

Effects of dialysis on the pharmacokinetics of salazosulfapyridine

Yuko Inami et al. Rheumatol Int. 2013 Feb.

Abstract

There was no standard or report for the treatment of rheumatoid arthritis (RA) patients on hemodialysis with Salazosulfapyridine (SASP). We examined the pharmacokinetics of SASP and its metabolites in RA patient on hemodialysis. Hemodialysis was started 2 h after administration of SASP at a dose of 250 or 500 mg. Blood samples were took 8 times during the observation period. The concentration of SASP and its metabolites (SP, Ac-SP) in blood sample were measured. There was no difference for the concentration of SASP before and after hemodialysis. Results showed SASP was nondialyzable, but SP and AC-SP were dialyzable. At a dose of 500 mg, AUC0-∞ of SASP and SP were higher than healthy volunteer. Therapy with SASP for hemodialysis RA should be started at a lower dose for adverse event risk.

PubMed Disclaimer

References

    1. Ryumachi. 2003 Jun;43(3):569-76 - PubMed
    1. Br Med J (Clin Res Ed). 1983 Oct 15;287(6399):1102-4 - PubMed
    1. J Rheumatol. 2002 Dec;29(12):2492-9 - PubMed
    1. Drugs. 2005;65(13):1825-49 - PubMed
    1. Arthritis Rheum. 2008 Jun 15;59(6):762-84 - PubMed

Publication types

LinkOut - more resources